Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zhenxing Wang
Institution:
Liaoning Cancer Hospital & Institute
Observed institution:
Liaoning Cancer Hospital & Institute
ORCID:
0000-0002-1696-263X
Observed ORCID:
0000-0002-1696-263X
OpenAlex ID:
A5100402730
Combining antibody-drug conjugates with immune checkpoint inhibitors: A new paradigm for breast cancer therapy
2025
·
Xiaoxiao Xu
, Tong Yu
, et al.
·
Cancer Treatment Reviews
·
27
Mesenchymal Stem Cell Therapy for ALI/ARDS: Therapeutic Potential and Challenges
2022
·
Zhenxing Wang
, Tong Yu
, et al.
·
Current Pharmaceutical Design
·
20
Antibody-drug conjugates in oncology: A spotlight on overcoming resistance
2025
·
Xiaoxiao Xu
, Tong Yu
, et al.
·
Critical Reviews in Oncology/Hematology
·
7
Beyond R-CHOP: The rise of antibody-drug conjugates in DLBCL
2026
·
Xiaoxiao Xu
, Meichen Liu
, et al.
·
Blood Reviews
·
1
Show more works
View as search
Works count:
4
Citation count:
55
H-index:
3
I10-index:
2
Year
Topic
Type